Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
CME Group Inc is a financial data & stock exchanges business based in the US. CME Group shares (CME) are listed on the NASDAQ and all prices are listed in US Dollars. CME Group employs 4,370 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Guided investing
Our top pick for
Building a portfolio
Our top pick for
Beginners
| Latest market close | $231.20 |
|---|---|
| 52-week range | $172.27 - $231.33 |
| 50-day moving average | $225.63 |
| 200-day moving average | $211.97 |
| Wall St. target price | $234.25 |
| PE ratio | 32.9189 |
| Dividend yield | $3.55 (1.61%) |
| Earnings per share (TTM) | $6.78 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $231.2 from 2022-01-20
| 1 week (2022-01-14) | 3.59% |
|---|---|
| 1 month (2021-12-21) | 2.66% |
| 3 months (2021-10-21) | 7.64% |
| 6 months (2021-07-21) | 9.06% |
| 1 year (2021-01-21) | 24.17% |
|---|---|
| 2 years (2020-01-21) | 11.77% |
| 3 years (2019-01-18) | 26.04% |
| 5 years (2017-01-20) | 98.18% |
Valuing CME Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CME Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CME Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, CME Group shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CME Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.0604. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CME Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CME Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3 billion.
The EBITDA is a measure of a CME Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.6 billion |
|---|---|
| Operating margin TTM | 55.39% |
| Gross profit TTM | $4.9 billion |
| Return on assets TTM | 1.03% |
| Return on equity TTM | 8.98% |
| Profit margin | 52.6% |
| Book value | $76.08 |
| Market capitalisation | $80.2 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CME Group.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 16.2
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CME Group's overall score of 16.2 (as at 12/31/2018) is excellent – landing it in it in the 10th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CME Group is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 6.41/100
CME Group's environmental score of 6.41 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 9.64/100
CME Group's social score of 9.64 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 8.65/100
CME Group's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CME Group is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CME Group scored a 1 out of 5 for controversy – the highest score possible, reflecting that CME Group has managed to keep its nose clean.
CME Group Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 16.2 |
|---|---|
| Total ESG percentile | 9.8 |
| Environmental score | 6.41 |
| Environmental score percentile | 5 |
| Social score | 9.64 |
| Social score percentile | 5 |
| Governance score | 8.65 |
| Governance score percentile | 5 |
| Level of controversy | 1 |
Dividend payout ratio: 92.68% of net profits
Recently CME Group has paid out, on average, around 92.68% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CME Group shareholders could enjoy a 1.61% return on their shares, in the form of dividend payments. In CME Group's case, that would currently equate to about $3.55 per share.
CME Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
CME Group's most recent dividend payout was on 13 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 26 December 2021 (the "ex-dividend date").
CME Group's shares were split on a 5:1 basis on 22 July 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your CME Group shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for CME Group shares which in turn could have impacted CME Group's share price.
Over the last 12 months, CME Group's shares have ranged in value from as little as $172.271 up to $231.33. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CME Group's is 0.4627. This would suggest that CME Group's shares are less volatile than average (for this exchange).
CME Group Inc. , together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions. The company also provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services; and transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, regulatory reporting, and trade processing. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company has strategic partnership with B3 S.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.